Table 3 Distribution of non-small cell lung cancer patients by histological subtype
Country | Author | Adenocarcinoma, No. (%) | Other subtypes No. (%) |
|---|---|---|---|
Overall | 1043 (85.8%) | 172 (14.2%) | |
Lebanon | Naderi et al. [9] | 182 (90.5%) | 19 (9.5%) |
Fakhruddin et al. [10] | 106 (100%) | 0 (0%) | |
Kattan et al. [11] | 157 (92.4%) | 13 (7.6%) | |
Egypt | Zaki et al. [12] | 23 (46%) | 27 (54%) |
Turkey | Unal et al. [13] | 32 (66.7%) | 16 (33.3%) |
Bircan et al. [14] | 14 (56%) | 11 (44%) | |
Saudi Arabia (SA) | Al-Kuraya et al. [15] | 26 (55.3%) | 21 (44.7%) |
SA-UAE-Qatar | Jazieh et al. [16] | 191 (83.0%) | 39 (17.0%) |
SA-UAE-Egypt | Jazieh et al. [17] | 175 (87.1%) | 26 (12.9%) |
Morocco | Errihani et al. [18] | 137 (100%) | 0 (0%) |